Sir Richard Sykes, Chairman Glaxo SmithKline

Date:
22 Oct 2001
Reference:
WF/M/AV/O/02/44
Part of:
Wellcome Foundation Ltd
  • Archives and manuscripts

About this work

Description

Topics discussed include:

impressions of Wellcome generally and assessment of the company prior to the merger in 1995;

relationship between WT and company;

the merger; assessment of Glaxo prior to merger;

Zantac;

research;

relationship between Wellcome in UK and USA;

Zovirax; staff selection post-merger;

general discussion re pharmaceutical industry.

Publication/Creation

22 Oct 2001

Physical description

2 audiocassettes Tape 46

Copyright note

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.

Terms of use

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.

Where to find it

  • Location Access
    Closed stores
    Can't be requested

    Note

Permanent link